From Policy to Action:
Callan JMB’s Role in Strengthening America’s Pharmaceutical Supply Chain

The White House’s new Executive Order to fill the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) underscores a national priority: securing a six-month supply of critical drug components, reducing reliance on foreign manufacturing, and building repositories that can withstand global disruptions.

At Callan JMB, this is the operational reality we manage every day. From our leadership’s role in building the Strategic National Stockpileto our rapid mobilization during COVID-19, our infrastructure already mirrors the scale and precision the White House envisions.

Why This Matters

Only about 10% of the APIs for U.S. prescription drugs are produced domestically. The White House directive highlights vulnerabilities that Callan JMB has been addressing for years through:

The White House’s call for greater pharmaceutical resilience closely parallels Callan JMB’s commitment to strengthening U.S. supply chains and building the infrastructure America needs for long-term health security.

In May, we announced a strategic partnership with Revival Health to strengthen U.S. supply chains for health, wellness, and longevity products—sectors that, like medicines, are central to national well-being. Through this partnership:

In parallel, the formation of Callan JMB Services (India) Private Limited provides a direct channel for securing APIs from India and supporting U.S.-based onshoring. With an operational warehouse underway in Pune, India, this initiative expands the pipeline of critical pharmaceutical inputs while maintaining full compliance and cold chain integrity. Through this effort:

A Legacy of Readiness

The White House directive to expand the list of essential medicines echoes Callan JMB’s history. Our teams helped build the Strategic National Stockpile, developing the very systems for storage, tracking, and deployment that policies now depend on. That legacy continues today in the way we scale operations with precision and reliability—whether for pharmaceuticals or health and wellness products.

Recognizing the Importance of National Action

Callan JMB applauds the White House’s recognition of the critical importance of American Pharmaceutical Supply Chain Resilience and its decisive action to establish and fill the Strategic Active Pharmaceutical Ingredients Reserve. Pairing national policy with proven infrastructure—and parallel private-sector initiatives like our strategic partnership with Revival Health and Callan JMB Services (India)—strengthens the nation’s ability to withstand disruptions and ensure continuity of care.

For Callan JMB, readiness is not a reaction to policy—it’s our daily practice. Every day, our facilities, systems, and teams are in place so that when the mandate comes—or the emergency strikes—the response is immediate. America’s pharmaceutical security doesn’t just depend on policy; it also depends on execution. Execution is where Callan JMB has always been ready—whether through national preparedness programs or innovative partnerships with global reach.